News and Trends 1 Jun 2023
Sanofi drug reduces disease activity in relapsing MS
…needs in multiple sclerosis today.” Gavin Giovannoni, chair of Neurology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, added: “Frexalimab has a…